Cash Flow Statement

Currency: USD

	Dec-2021	Mar-2022	Jun-2022	Sep-2022	Dec-2022	Mar-2023	Jun-2023	Sep-2023	Dec-2023	Mar-2024	Jun-2024	Sep-2024	Dec-2024
Operating Cash Flow
Net Income	8	12	8	8	11	7	4	(29)	(63)	(78)	(80)	(52)	(27)
Depreciation & Amortization	0	0	0	0	0	0	0	6	8	11	13	10	11
Change in Deffered Taxes	0	0	0	0	1	0	0	1	0	4	4	3	3
Stock-Based Compensation	0	0	0	0	0	0	0	5	5	15	16	13	16
Other Non-Cash Items	(10)	(14)	(10)	(11)	(14)	(12)	(9)	18	24	37	39	23	29
Cash Taxes Paid	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash Interest Paid	0	0	0	0	0	0	0	0	6	0	0	0	6
Change in Working Capital	0	1	1	2	2	3	4	8	12	65	28	(13)	(20)
Cash from Operating Activities	(1) N/A	(0) +63%	(1) -41%	(1) -20%	(1) -3%	(2) -98%	(2) +2%	(6) -304%	(18) -189%	28 N/A	(6) N/A	(29) -410%	(5) +83%
Investing Cash Flow
Capital Expenditures	0	0	0	0	0	0	0	(10)	(12)	(16)	(20)	(17)	(21)
Other Items	(334)	0	0	0	0	322	322	(15)	(23)	(339)	(337)	21	19
Cash from Investing Activities	(334) N/A	0 N/A	0 N/A	0 N/A	0 +208%	322 +86 916%	322 0%	(24) N/A	(36) -45%	(356) -901%	(357) 0%	4 N/A	(2) N/A
Financing Cash Flow
Net Issuance of Common Stock	336	0	0	0	0	(321)	(321)	56	65	386	386	9	50
Net Issuance of Debt	0	0	0	0	0	0	0	(0)	(1)	(1)	(3)	(4)	(5)
Cash Paid for Dividends	0	0	0	0	0	0	0	0	0	0	0	0	0
Other	(0)	(0)	0	0	0	0	1	0	(9)	0	(13)	(13)	(3)
Cash from Financing Activities	336 N/A	(0) N/A	0 N/A	0 N/A	0 N/A	(321) N/A	(321) +0%	56 N/A	55 -1%	376 +580%	370 -2%	(7) N/A	42 N/A
Change in Cash
Net Change in Cash	1 N/A	(1) N/A	(1) +12%	(1) -2%	(0) +35%	(1) -35%	(0) +50%	25 N/A	2 -94%	48 +2 900%	7 -85%	(32) N/A	34 N/A
Free Cash Flow
Free Cash Flow	(1) N/A	(0) +63%	(1) -41%	(1) -20%	(1) -3%	(2) -98%	(2) +2%	(16) -919%	(30) -93%	12 N/A	(26) N/A	(46) -77%	(26) +44%

American Oncology Network Inc
OTC:AONC